SERPINI1 pathogenic variants: An emerging cause of childhood-onset progressive myoclonic epilepsy

Am J Med Genet A. 2017 Sep;173(9):2456-2460. doi: 10.1002/ajmg.a.38317. Epub 2017 Jun 20.

Abstract

Progressive myoclonic epilepsies are rare neurodegenerative diseases with a wide spectrum of clinical presentations and genetic heterogeneity that render their diagnosis perplexing. Discovering new imputable genes has been an ongoing process in recent years. We present two pediatric cases of progressive myoclonic epilepsy with SERPINI1 pathogenic variants that lead to a severe presentation; we highlight the importance of including this gene, previously known as causing an adult-onset dementia-epilepsy syndrome, in the genetic work-up of childhood-onset progressive myoclonic epilepsies.

Keywords: SERPINI1; childhood; neuroserpin; progressive myoclonic epilepsy.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Age of Onset
  • Child
  • Humans
  • Male
  • Mutation
  • Myoclonic Epilepsies, Progressive / genetics*
  • Myoclonic Epilepsies, Progressive / physiopathology
  • Neuropeptides / genetics*
  • Neuroserpin
  • Serpins / genetics*

Substances

  • Neuropeptides
  • Serpins